av/aft-pharmaceutical-npv--big.svg

COM:AFTPHARM

AFT Pharmaceuticals

  • Stock

Last Close

2.65

22/11 04:00

Market Cap

309.35M

Beta: -

Volume Today

148.53K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
-2.43M
-
12.69M
622.95%
7.78M
38.69%
19.85M
155.05%
10.65M
46.32%
15.61M
46.51%
depreciation and amortization
319K
-
1.10M
244.83%
1.10M
0.36%
1.04M
5.43%
1.72M
65.13%
2.01M
16.76%
deferred income tax
-5.57M
-
-1.31M
76.48%
-13.89M
960.15%
-9.57M
31.07%
stock based compensation
252K
-
114K
54.76%
44K
61.40%
13K
70.45%
change in working capital
-4.68M
-
1.00M
121.46%
-11.64M
1,258.96%
-7.47M
35.79%
-6.95M
7.03%
1.50M
121.62%
accounts receivables
-2.05M
-
-7.30M
255.26%
-4.56M
37.56%
-4.96M
8.93%
-10.72M
115.92%
2.50M
123.29%
inventory
-746K
-
2.42M
425.07%
-10.92M
550.31%
154K
101.41%
-8.90M
5,877.27%
-6.66M
25.14%
accounts payables
-1.88M
-
5.88M
412.72%
3.84M
34.65%
-2.66M
169.35%
12.67M
575.63%
5.67M
55.27%
other working capital
-1
-
other non cash items
9.61M
-
-4.32M
144.98%
14.17M
427.74%
8.36M
40.97%
3.57M
57.28%
8.95M
150.43%
net cash provided by operating activities
-10.90M
-
-2.49M
77.14%
9.28M
472.12%
-2.43M
126.15%
12.22M
603.83%
9.00M
26.34%
25.55M
183.74%
investments in property plant and equipment
-634.23K
-
-122K
80.76%
-2.85M
2,238.52%
-3.46M
21.45%
-6.56M
89.38%
-6.23M
5.04%
-5.58M
10.37%
-9.18M
64.32%
-9.53M
3.81%
acquisitions net
purchases of investments
-856K
-
-3.00M
250.70%
-1.42M
52.73%
sales maturities of investments
other investing activites
-491.89K
-
-620K
26.04%
-9.41M
-
net cash used for investing activites
-625.23K
-
-1.60M
155.59%
-5.86M
266.40%
-4.88M
16.58%
-6.56M
34.36%
-6.23M
5.04%
-5.58M
10.37%
-9.18M
64.32%
-9.53M
3.81%
debt repayment
-7.42M
-
-60.32M
713.27%
-6.50M
89.22%
-6.14M
5.57%
-4M
34.83%
-5M
25%
common stock issued
37.87M
-
9.12M
75.91%
1.06M
88.33%
3K
-
12.40M
413,100%
295K
97.62%
475K
61.02%
common stock repurchased
-3.32M
-
-82K
97.53%
-188K
129.27%
52.28M
-
-723K
101.38%
dividends paid
-1.49M
-
-412K
-
-134K
67.48%
-566K
322.39%
-188K
66.78%
-1.15M
-
other financing activites
0.00
-
7.13M
-
11.27M
58.01%
-513K
104.55%
-2.46M
380.12%
1.93M
178.32%
-3.45M
279.00%
-3.62M
4.84%
net cash used provided by financing activities
33.07M
-
9.04M
72.66%
7.60M
15.95%
3.72M
51.01%
-9.12M
344.91%
2.52M
127.66%
-3.91M
255.19%
-6.98M
78.28%
-7.32M
4.90%
effect of forex changes on cash
1.60M
-
-457K
128.61%
24K
105.25%
240K
900%
5K
97.92%
49K
880.00%
78K
59.18%
-123K
257.69%
48K
139.02%
net change in cash
21.04M
-
-12.07M
157.39%
-9.13M
24.35%
146K
101.60%
-797K
645.89%
-2.91M
265.12%
4.73M
262.58%
-4.65M
198.27%
7.29M
256.83%
cash at beginning of period
4.23M
-
28.05M
562.58%
15.90M
43.31%
6.77M
57.43%
6.92M
2.16%
6.12M
11.52%
3.21M
47.56%
7.94M
147.43%
4.75M
40.19%
cash at end of period
25.27M
-
15.98M
36.77%
6.77M
57.63%
6.92M
2.16%
6.12M
11.52%
3.21M
47.56%
7.94M
147.43%
3.29M
58.55%
12.04M
265.85%
operating cash flow
-10.90M
-
-2.49M
77.14%
9.28M
472.12%
-2.43M
126.15%
12.22M
603.83%
9.00M
26.34%
25.55M
183.74%
capital expenditure
-634.23K
-
-122K
80.76%
-2.85M
2,238.52%
-3.46M
21.45%
-6.56M
89.38%
-6.23M
5.04%
-5.58M
10.37%
-9.18M
64.32%
-9.53M
3.81%
free cash flow
-634.23K
-
-122K
80.76%
-13.76M
11,176.23%
-5.96M
56.69%
2.71M
145.57%
-8.66M
418.86%
6.64M
176.68%
-173K
102.61%
16.02M
9,360.69%

All numbers in (except ratios and percentages)